Impairment of cognitive functioning during Sunitinib or Sorafenib treatment in cancer patients: a cross sectional study

BACKGROUND: Impairment of cognitive functioning has been reported in several studies in patients treated with chemotherapy. So far, no studies have been published on the effects of the vascular endothelial growth factor receptor (VEGFR) inhibitors on cognitive functioning. We investigated the object...

Descripción completa

Detalles Bibliográficos
Autores principales: Mulder, Sasja F, Bertens, Dirk, Desar, Ingrid ME, Vissers, Kris CP, Mulders, Peter FA, Punt, Cornelis JA, van Spronsen, Dick-Johan, Langenhuijsen, Johan F, Kessels, Roy PC, van Herpen, Carla ML
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3987809/
https://www.ncbi.nlm.nih.gov/pubmed/24661373
http://dx.doi.org/10.1186/1471-2407-14-219

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3987809/
https://www.ncbi.nlm.nih.gov/pubmed/24661373
http://dx.doi.org/10.1186/1471-2407-14-219

Ejemplares similares